1. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. (October 2015) Authors: Sagheddu, Claudia; Aroni, Sonia; De Felice, Marta; Lecca, Salvatore; Luchicchi, Antonio; Melis, Miriam; Muntoni, Anna Lisa; Romano, Rosaria; Palazzo, Enza; Guida, Francesca; Maione, Sabatino; Pistis, Marco Journal: Neuropharmacology Issue: Volume 97(2015) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. (November 2016) Authors: Scheggi, Simona; Melis, Miriam; De Felice, Marta; Aroni, Sonia; Muntoni, Anna Lisa; Pelliccia, Teresa; Gambarana, Carla; De Montis, Maria Graziella; Pistis, Marco Journal: Neuropharmacology Issue: Volume 110(2016) Part A Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Repeated exposure to JWH‐018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates. (29th June 2021) Authors: Pintori, Nicholas; Castelli, Maria Paola; Miliano, Cristina; Simola, Nicola; Fadda, Paola; Fattore, Liana; Scherma, Maria; Ennas, Maria Grazia; Mostallino, Rafaela; Flore, Giovanna; De Felice, Marta; Sagheddu, Claudia; Pistis, Marco; Di Chiara, Gaetano; De Luca, Maria Antonietta Journal: British journal of pharmacology Issue: Volume 178:Number 17(2021) Page Start: 3476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission. (24th July 2019) Authors: Cadoni, Cristina; De Felice, Marta; Corongiu, Silvia; Dessì, Christian; Espa, Elena; Melis, Miriam; Fenu, Sandro Journal: Addiction biology Issue: Volume 25:Number 5(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. (21st November 2018) Authors: De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco Journal: CNS neuroscience & therapeutics Issue: Volume 25:Number 5(2019) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗